
High-Grade Bond Market Kicks Off Busy Sales Day
US blue-chip companies unleashed a wave of bond sales on Monday as borrowers look to sell new debt
2023-10-31 03:48

China’s Junshi Nabs FDA Approval in Rare Success for US Foray
The US Food and Drug Administration has cleared the first China-developed cancer drug similar to Merck & Co.’s
2023-10-28 11:15

A Doctor With Brain Cancer Is Helping Transform Its Treatment
When Richard Scolyer was diagnosed with a deadly brain tumor in June, he grasped the test results as
2023-10-14 07:25

Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Bristol-Myers Squibb Co. has agreed to buy cancer drugmaker Mirati Therapeutics Inc. for $4.8 billion as the company
2023-10-09 09:26